Once‐daily USL255 as adjunctive treatment of partial‐onset seizures: Randomized phase III study

Steve Chung,Toufic Fakhoury,R. Edward Hogan,Venkatesh Nagaraddi,Ilan Blatt,Balduin Lawson,Stephan Arnold,Bob Anders,Annie Clark,Dawn Laine,R. Shawn Meadows,Mark Halvorsen

Once‐daily USL255 as adjunctive treatment of partial‐onset seizures: Randomized phase III study

2014

Steve Chung
Toufic Fakhoury
R. Edward Hogan
Venkatesh Nagaraddi
Ilan Blatt
Balduin Lawson
Stephan Arnold
Bob Anders
Annie Clark
Dawn Laine
R. Shawn Meadows
Mark Halvorsen

Objective To evaluate the efficacy and safety of USL255, Qudexy™ XR (topiramate) extended-release capsules, as an adjunctive treatment for refractory partial-onset seizures (POS) in adults taking one to three concomitant antiepileptic drugs.

Keywords:

Anesthesia
Topiramate
Epilepsy
Psychiatry
Diabetes mellitus
Medicine
Young adult
once daily
Refractory
adjunctive treatment
extended release
Concomitant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations